By: Melanie Viquez, Yellow Brick Consulting

When your construction timeline is locked, your activation schedule is tight, and your equipment list is approved, there’s one thing you can’t control — external risks. In 2025, tariffs on imported electronics and medical devices have become silent disruptors behind many hospital activation delays.

Even as the U.S. healthcare system continues to build, renovate, and modernize, a shifting tariff landscape is extending lead times for essential equipment. From patient monitoring systems and infusion pumps to the digital clocks that keep entire facilities synchronized, tariff-driven reengineering and supplier rerouting are slowing the delivery of critical components that brings a hospital to life.

The new tariff reality

Recent trade actions have created a patchwork of overlapping duties on medical devices and components sourced from China and Southeast Asia. Some categories now carry combined rates exceeding 50% (https://www.aha.org/news/headline/2025-10-17-aha-expresses-concernspotential-tariffs-ppe-other-medical-goods), while others have temporary exemptions under review. Hospitals and suppliers alike are navigating a moving target one that changes as investigations and countermeasures unfold.

The U.S. government’s Section 232 investigation into medical supplies, launched this fall, adds another layer of uncertainty. Meanwhile, manufacturers are reporting steep production costs, cancelled U.S. orders, and delays as they re-engineer or relocate assembly lines.

The American Hospital Association (AHA) (https://www.aha.org/lettercomment/2025-10-17-aha-responds-department-commerces-rfi-ppe-and-medical-equipment) and industry groups such as AdvaMed have publicly urged policymakers to exclude essential healthcare products from these tariffs, warning that they could compromise access to vital equipment. But until that happens, healthcare construction and activation teams must treat tariff exposure as a project risk — not an afterthought.

How tariffs translate into activation delays

Even when a product is labeled “Made in the USA,” its components often aren’t. A patient monitor, for example, may contain circuit boards, power modules, or display panels produced in China or Malaysia. When tariffs apply to any part of that chain, the ripple effects cascade
quickly:

1. Price pressure: Manufacturers pass through higher landed costs or impose temporary surcharges.
2. Re-engineering: Components are swapped for alternatives, triggering new quality testing or regulatory recertification.
3. Supplier rerouting: Shifting assembly to new facilities often resets the production queue and extends delivery windows.
4. Allocation limits: Original Equipment Manufacturers (OEMs) prioritize large health systems or high-margin customers, leaving smaller projects waiting.

The result? Key activation items that once shipped in 8–10 weeks can now take 16–20 weeks or longer — even before considering logistics or installation sequencing.

The top product categories at risk

Based on recent industry data, the following categories have been identified has vulnerable to tariff-related delays and shortages:

• Imaging components and subsystems: Ultrasound transducer modules, detector panels, MRI console parts (8–20+ week delays).
• Patient monitoring systems and telemetry boards: Specialized PCBs and chipsets (6–16 weeks).
• Automated dispensing cabinets: Screens and sensors used in medication management (8–14 weeks).
• Infusion pumps and smart IV devices: Firmware-dependent systems (6–12 weeks).
• Network and wireless hardware: Routers, PoE switches, and access points (4–12+ weeks).
• Touchscreen displays and mobile workstations: Panels and processors assembled overseas (6–16 weeks).
• Digital clocks and synchronized time systems: Often overlooked but critical to testing and operations (4–8 weeks).

While each delay may seem manageable in isolation, multiple lagging components can ripple across readiness milestones and delay the overall occupancy timeline.

What project and procurement teams can do now

1. Identify high-risk items early.
   Start with your top 25 equipment categories and map each by vendor, origin, and regulatory sensitivity.
2. Confirm lead times directly with manufacturers.
   Don’t rely solely on distributor data — request updated factory lead times and certification that no design or component changes are pending.
3. Negotiate tariff clauses in contracts.
   Require vendors to disclose country of origin and current tariffs at the time of purchase order execution. Include language that limits pass-through surcharges or mandates advance notice of price changes.
4. Build lead-time buffers into your schedule.
   For high-risk items, apply 20–30% schedule float. Flag any equipment dependencies tied to installation sequencing, such as network activation or pharmacy readiness.
5. Secure alternate suppliers or models.
   If your primary vendor’s equipment is tariff-affected, identify equivalent systems from U.S. or non-affected regions. Maintain flexibility in your specifications where clinically appropriate.
6. Pre-purchase or stage critical items.
   Where storage permits, buy early. If not, explore vendor-owned inventory or local warehousing or staging options.
7. Stay close to your procurement consultant and supply chain team.
   They can help assess which equipment lines are most affected in your region and navigate group purchasing contracts or tariff exclusions.

Contract language worth revisiting

Hospitals executing new contracts should work closely with legal and procurement teams to ensure the following:

• Origin certification: Require disclosure of country of manufacture and subcomponent sources.
• Fixed-price periods: Lock pricing for a defined term or require written justification for any tariff-driven increase.
• Lead-time notice: Vendors must notify buyers within 30–60 days of any expected delay or cost change.
• Priority allocation clause: Define escalation paths if supply is constrained.
• Force majeure language: Ensure tariffs trigger collaboration, not automatic cancellation or penalty.

Even small contractual refinements can help mitigate both cost and timeline exposure later.

The takeaway: plan, buffer, and verify

Tariffs and trade policies may feel distant from the realities of hospital activation — but their impact is very real. Lead-time extensions, re-engineered models, and cost escalations are no longer isolated events; they’re structural risks that must be tracked and managed alongside
construction milestones.

To keep projects on schedule, engage early and stay aligned:

• Confirm with your equipment procurement consultant which products face risk in your market.
• Coordinate with your health system supply chain to understand any region-specific challenges or alternative sourcing options.
• Build procurement checkpoints into your activation timeline to verify that each system — from monitoring to medication dispensing — arrives ready for Day 1 operations.

Make tracking the policy landscape and supply chain data part of your readiness plan to help teams stay ahead of risk.